MedPage Today (8/9) reports that a study published online in the Journal of the American College of Cardiology found that “despite increasing HDL cholesterol levels, the addition of niacin (Niaspan) to statin therapy did not improve the beneficial functions of HDL cholesterol, which could explain the drug’s failure to improve clinical outcomes in recent large clinical trials.”
POSTED BY: Steven
Almany M.D.
No comments:
Post a Comment